Search Results - Rovithi, Maria N.

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Epithelial Transfer of the Tyrosine Kinase Inhibitors Erlotinib, Gefitinib, Afatinib, Crizotinib, Sorafenib, Sunitinib, and Dasatinib: Implications for Clinical Resistance

    Epithelial Transfer of the Tyrosine Kinase Inhibitors Erlotinib, Gefitinib, Afatinib, Crizotinib, Sorafenib, Sunitinib, and Dasatinib: Implications for Clinical Resistance by Honeywell, Richard J., Kathmann, Ietje, Giovannetti, Elisa, Tibaldi, Carmelo, Smit, Egbert F., Rovithi, Maria N., Verheul, Henk M.W., Peters, Godefridus J.

    Published in Cancers
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Abstract 1374: Cross-resistance and sensitivity of sunitinib resistant tumor cells

    Abstract 1374: Cross-resistance and sensitivity of sunitinib resistant tumor cells by Gotink, Kristy J., Broxterman, Henk J., de Haas, Richard R., Rovithi, Maria N., Pili, Roberto, Verheul, Henk MW

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Abstract 3608: Measurement of kinase activity in cancer cell lines and tumor tissue using a tyrosine kinase peptide substrate array

    Abstract 3608: Measurement of kinase activity in cancer cell lines and tumor tissue using a tyrosine kinase peptide substrate array by Labots, Mariette, Gotink, Kristy J., Dekker, Henk, van der Mijn, Johannes C., Broxterman, Henk J., Rovithi, Maria N., Jiménez, Connie R., Verheul, Henk M.W.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: